Foghorn Therapeutics Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6
Rok finansowy 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 1 19 34 23
Przychód Δ r/r 0.0% 0.0% inf% 206.7% 1357.8% 77.6% -33.8%
Marża brutto 0.0% -inf% -13322.1% -469.7% 99.9% 74.6% 100.0%
EBIT (mln) -26 -51 -69 -101 -117 -108 -103
EBIT Δ r/r 0.0% 96.1% 34.2% 47.0% 16.3% -7.9% -4.8%
EBIT (%) 0.0% 0.0% -15937.4% -7637.1% -609.2% -315.9% -454.3%
Koszty finansowe (mln) 0 1 1 2 -12 0 0
EBITDA (mln) -26 -50 -66 -95 -117 -99 -97
EBITDA(%) 0.0% 0.0% -15396.0% -7198.9% -609.2% -290.6% -429.9%
Podatek (mln) 0 1 1 2 -0 4 0
Zysk Netto (mln) -26 -52 -70 -103 -109 -98 -87
Zysk netto Δ r/r 0.0% 96.2% 35.1% 47.9% 5.5% -9.6% -12.0%
Zysk netto (%) 0.0% 0.0% -16227.7% -7826.1% -566.2% -288.2% -383.2%
EPS -1.34 -1.4 -1.9 -2.78 -2.62 -2.34 -1.58
EPS (rozwodnione) -1.34 -1.4 -1.9 -2.78 -2.62 -2.34 -1.58
Ilośc akcji (mln) 20 37 37 37 42 42 55
Ważona ilośc akcji (mln) 20 37 37 37 42 42 55
Waluta USD USD USD USD USD USD USD